Literature DB >> 15230464

Botulinum toxin in the management of cerebral palsy.

Rosalind J Jefferson1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15230464     DOI: 10.1017/s0012162204000817

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


× No keyword cloud information.
  5 in total

Review 1.  Pharmacologic interventions for reducing spasticity in cerebral palsy.

Authors:  Dilip R Patel; Olufemi Soyode
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

Review 2.  Botulinum toxin in children with cerebral palsy.

Authors:  Pratibha Singhi; Munni Ray
Journal:  Indian J Pediatr       Date:  2004-12       Impact factor: 1.967

3.  Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.

Authors:  Kristie Bjornson; Ross Hays; Cathy Graubert; Robert Price; Francine Won; John F McLaughlin; Morty Cohen
Journal:  Pediatrics       Date:  2007-07       Impact factor: 7.124

Review 4.  Management of spasticity in children with cerebral palsy.

Authors:  Alireza Shamsoddini; Susan Amirsalari; Mohammad-Taghi Hollisaz; Alireza Rahimnia; Amideddin Khatibi-Aghda
Journal:  Iran J Pediatr       Date:  2014-05-09       Impact factor: 0.364

5.  The effects of botulinum toxin type A on improvement and dynamic spastic equinus correction in children with cerebral palsy - preliminary results.

Authors:  Hristina Colovic; Lidija Dimitrijevic; Ivona Stankovic; Dejan Nikolic; Dragana Radovic-Janosevic; Dragoljub Zivanovic
Journal:  Arch Med Sci       Date:  2014-10-23       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.